Tags

Type your tag names separated by a space and hit enter

Oseltamivir resistance--disabling our influenza defenses.
N Engl J Med. 2005 Dec 22; 353(25):2633-6.NEJM

Authors+Show Affiliations

Moscona A
Department of Pediatrics at Weill Medical College of Cornell University, New York, USA.

MeSH

AcetamidesBinding SitesChildDrug Resistance, ViralGuanidinesHumansInfluenza A Virus, H5N1 SubtypeInfluenza, HumanMutationNeuraminidaseOseltamivirPyransSelf AdministrationSialic AcidsZanamivir

Pub Type(s)

Comment
Journal Article

Language

eng

PubMed ID

16371626

Clinical Trial Links

Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications

Citation

Moscona, Anne. "Oseltamivir Resistance--disabling Our Influenza Defenses." The New England Journal of Medicine, vol. 353, no. 25, 2005, pp. 2633-6.
Moscona A. Oseltamivir resistance--disabling our influenza defenses. N Engl J Med. 2005;353(25):2633-6.
Moscona, A. (2005). Oseltamivir resistance--disabling our influenza defenses. The New England Journal of Medicine, 353(25), 2633-6.
Moscona A. Oseltamivir Resistance--disabling Our Influenza Defenses. N Engl J Med. 2005 Dec 22;353(25):2633-6. PubMed PMID: 16371626.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Oseltamivir resistance--disabling our influenza defenses. A1 - Moscona,Anne, PY - 2005/12/24/pubmed PY - 2005/12/31/medline PY - 2005/12/24/entrez SP - 2633 EP - 6 JF - The New England journal of medicine JO - N Engl J Med VL - 353 IS - 25 SN - 1533-4406 UR - https://www.unboundmedicine.com/medline/citation/16371626/Oseltamivir_resistance__disabling_our_influenza_defenses_ DB - PRIME DP - Unbound Medicine ER -